Keyword: Pharma

Plant Construction & Process Technology

Porsche Consulting on Lessons from the Auto Industry

11.05.2011 - Going Lean - The pharmaceutical industry is subject to very special requirements: strict approval procedures, rising cost pressures in the healthcare industry and lost sales due to...

News

U.S. Top Court Questions State Drug Data Limits

27.04.2011 - U.S. Supreme Court justices sharply questioned on Tuesday whether a state may prohibit the use of prescription drug records for marketing, expressing concerns that it violated free...

News

Genome Study Brings Blood Cancer Into Sharp Focus

24.03.2011 - Scientists have mapped out the full genetic code of 38 people with multiple myeloma, uncovering never-before suspected genes that play a role in the blood cancer and showing that a...

News

Russia Set for More Inward Pharma Investment

10.02.2011 - More global drugmakers will soon announce plans to establish a local presence in Russia in response to government measures to boost its domestic sector and cut dependence on...

News

Karl-Ludwig Kley: Merck KGaA May Sell Non-Prescription Drugs Business

01.02.2011 - Germany's Merck KGaA may sell its non-prescription drugs business, the group's chief executive told the Financial Times, in the latest sign of change at the family-controlled drugs...

News

Lonza Expects Solid Growth in 2011, 2010 Net Up 79%

27.01.2011 - Swiss drugs industry supplier Lonza said on Wednesday it expects solid growth in 2011 after meeting forecasts with a 79 percent rise in full-year net profit. Net profit at the...

Plant Construction & Process Technology

The Pharmaceutical Industry On The Move

26.01.2011 - Shifting Priorities - Our world is faced with a growing and aging population. In developed countries, people search for wellness, while in emerging economies, populations seek...

News

Novartis Buys Cancer Diagnosis Specialist Genoptix For $470 Million

25.01.2011 - Swiss drugmaker Novartis is strengthening its personalized medicine and cancer portfolio with the $470 million buy of U.S. cancer diagnostics company Genoptix. The deal, which...